ILK was significantly highly expressed in the tissues of ovarian cancer patients at the ages older than 50, in III-IV stages, or with lymphatic metastases than in the tissues of ovarian cancer patients younger than 50, I-II stages, or without lymphatic metastases, respectively (Table S2). This evidence concerns the gene ILK and ovarian carcinoma.